Observational studyPediatric nephrology (Berlin, Germany)2026
Beyond the kidney: prevalence of extrarenal complications and their long-term sequelae in Shiga toxin-producing Escherichia coli hemolytic uremic syndrome.
Observational study in Pediatric nephrology (Berlin, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundShiga toxin-producing Escherichia coli hemolytic uremic syndrome (STEC-HUS) is a leading cause of acute kidney injury in children, but its systemic nature can lead to extrarenal complications. While long-term kidney sequelae are well-documented, data on the long-term consequences of extrarenal involvement are scarce. This study aimed to determine the prevalence of extrarenal complications in STEC-HUS patients, compare acute phase findings between patients with and without extrarenal involvement, and describe the long-term sequelae.
methodsRetrospective and observational study of 221 children under 18 years old with STEC-HUS admitted between 2005 and 2024. Clinical and laboratory data from the acute phase were analyzed. Extrarenal involvement during the acute phase and the long-term outcome were described.
resultsExtrarenal complications were observed in 46 (21%) patients and nearly half of them had compromise of ≥ 2 organs. Central nervous system involvement was the most frequent and the leading cause of death, followed by severe gastrointestinal, cardiac, and ocular compromise. Patients with extrarenal involvement had a significantly higher mortality rate (15.2% vs. 1%, p < 0.0001) and 91% required dialysis. Multivariate logistic regression analysis identified dialysis requirement, leukocytosis > 16,100 cells/mm
conclusionsExtrarenal involvement was associated with increased morbidity and mortality and a non-negligible prevalence of long-term sequelae. These findings highlight the importance of screening for extrarenal complications and sequelae during long-term follow up.
Indexed as
Identifiers
42228085What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.